Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Impact BioMedical Inc. before investing.

In this article, we go over a few key elements for understanding Impact BioMedical Inc.’s stock price such as:

• Impact BioMedical Inc.’s current stock price and volume
• Why Impact BioMedical Inc.’s stock price changed recently
• Upgrades and downgrades for IBO from analysts
• IBO’s stock price momentum as measured by its relative strength

About Impact BioMedical Inc. (IBO)

Before we jump into Impact BioMedical Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use as health supplements and medications. Further, it is developing 3F (functional fragrance formulation), a formulation of botanical ingredients. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS BioHealth Security, Inc

Want to learn more about Impact BioMedical Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Impact BioMedical Inc..

Impact BioMedical Inc.’s Stock Price as of Market Close

As of April 17, 2026, 4:00 PM, CST, Impact BioMedical Inc.’s stock price was $0.645.

Impact BioMedical Inc. is down 2.73% from its previous closing price of $0.663.

During the last market session, Impact BioMedical Inc.’s stock traded between $0.600 and $0.660. Currently, there are approximately 89.77 million shares outstanding for Impact BioMedical Inc..

Impact BioMedical Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Impact BioMedical Inc. Stock Price History

Impact BioMedical Inc.’s (IBO) price is currently up 7.5% so far this month.

During the month of April, Impact BioMedical Inc.’s stock price has reached a high of $0.720 and a low of $0.555.

Over the last year, Impact BioMedical Inc. has hit prices as high as $1.950 and as low as $0.362. Year to date, Impact BioMedical Inc.’s stock is up 27.72%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Impact BioMedical Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 17, 2026, there were analysts who downgraded Impact BioMedical Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Impact BioMedical Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Impact BioMedical Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Impact BioMedical Inc. (IBO) by visiting AAII Stock Evaluator.

Relative Price Strength of Impact BioMedical Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 17, 2026, Impact BioMedical Inc. has a weighted four-quarter relative price strength of 12.44%, which translates to a Momentum Score of 82 and is considered to be Very Strong.

Want to learn more about how Impact BioMedical Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Impact BioMedical Inc. Stock Price: Bottom Line

As of April 17, 2026, Impact BioMedical Inc.’s stock price is $0.645, which is down 2.73% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Impact BioMedical Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.